Curcumin Therapy in Inflammatory Bowel Disease: A Pilot Study
Author(s) -
Peter R. Holt,
Seymour Katz,
Robert Kirshoff
Publication year - 2005
Publication title -
digestive diseases and sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.14
H-Index - 124
eISSN - 1573-2568
pISSN - 0163-2116
DOI - 10.1007/s10620-005-3032-8
Subject(s) - curcumin , medicine , hepatology , ulcerative colitis , inflammatory bowel disease , placebo , proctitis , gastroenterology , concomitant , crohn's disease , disease , pharmacology , pathology , alternative medicine
Curcumin, a natural compound used as a food additive, has been shown to have anti-inflammatory and antioxidant properties in cell culture and animal studies. A pure curcumin preparation was administered in an open label study to five patients with ulcerative proctitis and five with Crohn's disease. All proctitis patients improved, with reductions in concomitant medications in four, and four of five Crohn's disease patients had lowered CDAI scores and sedimentation rates. This encouraging pilot study suggests the need for double-blind placebo-controlled follow-up studies.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom